These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9628086)

  • 1. Clonidine challenge in childhood anxiety disorder.
    Sallee FR; Richman H; Sethuraman G; Dougherty D; Sine L; Altman-Hamamdzic S
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):655-62. PubMed ID: 9628086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulatory tests of growth hormone secretion in prepubertal major depression: depressed versus normal children.
    Ryan ND; Dahl RE; Birmaher B; Williamson DE; Iyengar S; Nelson B; Puig-Antich J; Perel JM
    J Am Acad Child Adolesc Psychiatry; 1994; 33(6):824-33. PubMed ID: 8083139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenfluramine challenge in anxious children.
    Sallee FR; Vrindavanam NS; Liu H; Sethuraman G; Sine L
    Hum Psychopharmacol; 2000 Dec; 15(8):619-629. PubMed ID: 12404615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function.
    Cameron OG; Abelson JL; Young EA
    Biol Psychiatry; 2004 Dec; 56(11):875-83. PubMed ID: 15576065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults.
    Kimber J; Sivenandan M; Watson L; Mathias CJ
    Growth Horm IGF Res; 2001 Apr; 11(2):128-35. PubMed ID: 11472079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone response to growth hormone-releasing hormone and clonidine in depression.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Biol Psychiatry; 1995 Sep; 38(5):325-9. PubMed ID: 7495927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH response to intravenous clonidine challenge correlates with history of childhood trauma in personality disorder.
    Lee RJ; Fanning JR; Coccaro EF
    J Psychiatr Res; 2016 May; 76():38-43. PubMed ID: 26874268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yohimbine challenge in children with anxiety disorders.
    Sallee FR; Sethuraman G; Sine L; Liu H
    Am J Psychiatry; 2000 Aug; 157(8):1236-42. PubMed ID: 10910785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines].
    Pitchot W; Hansenne M; Gonzalez Moreno A; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1995; 95(4-5):210-33. PubMed ID: 8525861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M; Wilkins A; Werstiuk ES; Steiner M
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone response to growth hormone-releasing hormone and clonidine in young monkeys: correlation with behavioral characteristics.
    Coleman K; Dahl RE; Ryan ND; Cameron JL
    J Child Adolesc Psychopharmacol; 2003; 13(3):227-41. PubMed ID: 14642012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSM-IV obsessive-compulsive personality disorder: prevalence in patients with anxiety disorders and in healthy comparison subjects.
    Albert U; Maina G; Forner F; Bogetto F
    Compr Psychiatry; 2004; 45(5):325-32. PubMed ID: 15332194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone response to apomorphine in obsessive-compulsive disorder.
    Pitchot W; Hansenne M; Moreno AG; Ansseau M
    J Psychiatry Neurosci; 1996 Nov; 21(5):343-5. PubMed ID: 8973055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity of the clonidine and guanfacine tests (alpha-2-adrenergic agonists) as pharmacologic stimulants of growth hormone. Effects on plasma cortisol].
    Durá Travé T; Juste Ruiz M; González Montero R; Gutiérrez Terán M; Mauri Dot M; Moya Benavent M
    An Esp Pediatr; 1996 Dec; 45(6):575-8. PubMed ID: 9133220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration.
    Baumann MH; Milchanowski AB; Rothman RB
    Neuroscience; 2004; 125(3):683-90. PubMed ID: 15099682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone response to clonidine predicts aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Eryavec G; Van Reekum R; Khan LR
    Psychoneuroendocrinology; 2004 Oct; 29(9):1192-7. PubMed ID: 15219643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder.
    Kluge M; Schüssler P; Weikel J; Dresler M; Zuber V; Querfurt F; Yassouridis A; Steiger A
    Psychoneuroendocrinology; 2006 Oct; 31(9):1098-104. PubMed ID: 16965859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.